Differential alterations in metabolic pattern of the spliceosomal UsnRNAs during pre-malignant lung lesions induced by benzo(a)pyrene: Modulation by tea polyphenols

Molecular and Cellular Biochemistry

Volumn 289, Issue 1-2, 2006, Pages 149-157

  Manna, Sugata ^a   Banerjee, Sarmistha ^a   Saha, Prosenjit ^a   Roy, Anup ^b   Das, Sukta ^a   Panda, Chinmay Kr ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Benzo(a)pyrene; Cancer chemoprevention; Epicatechin gallate; Epigallocatechin gallate; Lung cancer; UsnRNAs

Indexed keywords

ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; POLYPHENOL; SMALL NUCLEAR RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FEMALE; HISTOPATHOLOGY; HYPERPLASIA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; MALE; MODULATION; MOUSE; NONHUMAN; PNEUMONIA; PRECANCER; RNA ISOLATION; RNA METABOLISM; SPLICEOSOME; TEA;

ANIMALS; BENZO(A)PYRENE; CATECHIN; FLAVONOIDS; LUNG; LUNG NEOPLASMS; MICE; PHENOLS; PRECANCEROUS CONDITIONS; RNA, SMALL NUCLEAR; SPLICEOSOMES; TEA;

EID: 33748302757     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9158-y     Document Type: Article

References (66)

1. Reddy R, Busch H: Small nuclear RNAs: RNA sequences, structure and modifications. In: ML Brinstiel (ed). Structure and function of major and minor small nuclear ribonucleoprotein particles. Springer-Verlag, Heidelberg, pp 1-37, 1988
2. Makarov EM, Makarova OV, Urlaub H, Getzel M, Will CL, Wilm M, Lührmann R: Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science 298: 2205-2208, 2002
3. Jurica MS, Moore MJ: Pre-mRNA splicing: Awash in a sea of proteins. Mol Cell 12: 5-14, 2003
4. Mattaj IW, Tollervey D, Séraphin B: Small nuclear RNAs in messenger RNA and ribosomal RNA processing. FASEB J 7: 47-53, 1993
5. Grabowski PJ, Sharp PA: Affinity chromatography of splicing complexes: U2, U5, and U4+U6 small nuclear ribonucleoprotein particles in the spliceosome. Science 233: 1294-1299, 1986
6. Berget SM, Robberson BL: U1, U2, and U4/U6 Small nuclear ribonucleoproteins are required for in vitro splicing but not polyadenylation. Cell 46: 691-696, 1986
7. Theissen H, Rinke J, Traver CN, Lührmann R, Appel B: Novel structure of a human U6 snRNA pseudogene. Gene 36: 195-199, 1985
8. 1-like RNA are present in plant nuclei. Nucl Acids Res 15(2): 543-560, 1987
9. Will CL, Lührmann R: Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 13: 290-301, 2001
10. Dahlberg JE, Lund E: The genes and transcription of the major small, nuclear RNAs. In: ML Brinstiel (ed). Structure and function of major and minor small nuclear ribonucleoprotein particles. Springer-Verlag, Heidelberg, pp 38-70, 1988
11. Ray R, Panda CK, Chakraborty BK, Mukherji S, Chaudhury K, Roychoudhury J: Changes in UsnRNA biosynthesis during rat liver regeneration. Mol Cell Biochem 141: 71-77, 1994
12. Ray R, Ray K, Panda CK: Differential alterations in metabolic pattern of the six major UsnRNAs during development. Mol Cell Biochem 177: 79-88, 1997
13. Ray R, Chakraborty BK, Ray K, Mukherji S, Roy Choudhury J, Panda CK: Effect of anthracycline antitumor antibiotics (andriamycin and nogalamycin) and cycloheximide on the biosynthesis and processing of major UsnRNAs. Mol Cell Biochem 162: 75-82, 1996
14. Lund E, Kahan B, Dahlberg JE: Differential control of U1 small nuclear RNA expression during mouse development. Science 229(4719): 1271-1274, 1985
15. Lund E, Dahlberg JE: Differential accumulation of U1 and U4 small nuclear RNAs during Xenopus development. Genes Dev 1(1): 39-46, 1987
16. Hanley BA, Schuler MA: Developmental expression of plant snRNAs. Nucl Acids Res 19(22): 6319-6325, 1991
17. Forbes DJ, Kirschner MW, Caput D, Dahlberg JE, Laund E: Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis. Cell 38(3): 681-689, 1984
18. Leader D, Connelly S, Filipowicz W, Waugh R, Brown JW: Differential expression of U5snRNA gene variants in maize (Zea mays) protoplasts. Plant mol Biol 21(1): 133-143, 1993
19. Cheng Y, Lund E, Kahan BW, Dahlberg JE: Control of mouse U1 snRNA gene expression during in vitro differentiation of mouse embryonic stem cells. Nucl Acids Res 25(11): 2197-2204, 1997
20. Lund E, Bostock CJ, Dahlberg JE: The transcription of Xenopus laevis embryonic U1 snRNA genes changes when oocytes mature into eggs. Genes Dev 1: 47-56, 1987
21. Cáceres JF, McKenzie D, Thimmapaya R, Lund E, Dahalberg JE: Control of mouse U1a and U1b snRNA gene expression by differential transcription. Nucl Acids Res 20(16): 4247-4254, 1992
22. Tanaka M, Lai JS, Herr W: Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68(4): 755-767, 1992
23. Mivake JH, Botros IW, Stumph WE: Differential protein-DNA interactions at the promoter and enhancer regions of developmentally regulated U4 snRNA genes. Gene Expr 2(2): 161-173, 1992
24. Hamad K, Kumazaki T, Mizuno K, Yokoro K: A small nuclear RNA U5, can transform cells in vitro. Mol Cell Biol 9(10): 4345-4356, 1989
25. Drift PVD, Chan A, Laureys G, Roy NV, Sickmann G, Dunnen J, Westerveld A, Speleman F, Versteeg R: Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36. Genes Chr Cancer 14(1): 35-42, 1995
26. Eliceiri BP, Choudhury K, Scott QO, Eliceiri GL: Ultraviolate light-induced inhibition of small nuclear RNA synthesis. J Cell Physiol 138(3): 586-592, 1989
27. Thirunavukkarasu C, Choudhury K, Ninichuck AJ, Choudhury I, Eliceiri G: Effect of ultraviolate light on the expression of genes for human U1 RNA. J Cell Physiol 137(1): 55-64, 1988
28. Morra DS, Eliceiri BP, Eliceiri GL: Effect of UV light on small nuclear RNA synthesis: Increased inhibition during postirradiation cell incubation. Mol Cell Biol 6(3): 745-750, 1986
29. Li Z, Yu A, Weiner AM: Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function. J Virol 72(5): 4183-4191, 1998
30. Liao D, Yu A, Weiner AM: Coexpression of the adenovirus 12E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus. Virology 254: 11-23, 1999
31. Gridasova AA, Henry RW: The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerase II and III independently of sequence-specific DNA binding. Mol cell Biol 25(8): 3247-3260, 2005
32. Crains CA, White RJ: P53 is a general repressor of RNA polymerase III transcription. EMBO J 17: 3112-3123, 1998
33. Chesnokov I, Chu WM, Botchan MR, Schmid CW: P53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner. Mol. Cell Biol 16: 7084-7088, 1996
34. Ilyas M, Straub J, Tomlinson IPM, Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer 35(3): 335-351, 1999
35. Loeb LA, Loeb KR, Anderson JP: Multiple mutations and cancer. Proc Natl Acad Sci USA 100(3): 776-781, 2003
36. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001
37. Yun TK, Kim SH, Lee YS: Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer Res 15: 839-846, 1995
38. Yang CS, Maliakal P, Meng X: Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42: 25-54, 2002
39. Balasubramanian S, Sturniolo MT, Dubyak GR, Eckert RL: Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate-dependent differentiation but not apoptosis. Carcinogenesis 26(6): 1100-1108, 2005
40. Hsu S, Yamamoto T, Borke J, Walsh DS, Singh B, Rao S, Takaaki K, Nah-Do N, Lapp C, Lapp D, Foster E, Bollag WB, Lewis J, Wataha J, Osaki T, Schuster G: Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. J Pharmacol Exp Ther 312(3): 884-890, 2005
41. Eckert RL, Crish JF, Efimova T, Balasubramanian S: Antioxidants regulate normal human keratinocyte differentiation. Biochem Pharmacol 68(6): 1125-1131, 2004
42. Lung HL, Ip WK, Wong CK, Mak NK, Chen ZY, Leung KN: Anti-proliferative and differentiation-inducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophilic leukemia EoL-1 cell line. Life Sci 72(3): 257-268, 2002
43. Xu Y, Ho CT, Amin SG, Han C, Chung FL: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52: 3875-3879, 1992
44. Singh AK, Seth P, Anthony P, Husain MM, Madhavan S, Mukhtar H, Maheshwari RK: Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch Biochem Biophys 401(1): 29-37, 2002
45. Baek SJ, Kim JS, Jackson FR, Eling TE, McEntee MF, Lee SH: Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis 25(12): 2425-2432, 2004
46. Chomezynski P, Saccchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
47. Choudhury K, Choudhury I, Jones RW, Thirunavukkarasu C, Eliceiri GL: Metabolism of U6 RNA species in nonirradiated and UV-irradiated mammalian cells. J Cell Physiol 137(3): 529-536, 1988
48. Baird WM, Hooven LA, Mahadevan B: Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45: 106-114, 2005
49. Luch A: Nature and nurture-lessons from chemical carcinogenesis. Nature reviews (cancer) 5: 113-125, 2005
50. Rubin H: Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis 22(12): 1903-1930, 2001
51. Jernstrom B, Graslund A: Covalent binding of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxides to DNA: Molecular structures, induced mutations and biological consequences. Biophys Chem 49(3): 185-199, 1994
52. Wang A, Gu J, Kremer KJ, Powell KL, Mistry H, Simhambhatla P, Aldaz CM, Gaddis S, MacLeod MC: Response of human mammary epithelial cells to DNA damage induced by BPDE: Involvement of novel regulatory pathways. Carcinogenesis 24(2): 225-234, 2003
53. Solhaug A, Refsnes M, Låg M, Schwarze PE, Husøy T, Holme JA: Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 25(5): 809-819, 2004
54. Nakanishi Y, Pei XH, Takayama K, Bai F, Izumi M, Kimotsuki K, Inoue K, Minami T, Wataya H, Hara N: Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. Am J Respir Cell Mol Biol 22(6): 747-754, 2000
55. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N: Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor κB activity. J Biol Chem 274(49): 35240-35246, 1999
56. Roebuck KA, Szeto DP, Green KP, Fan QN, Stumph WE: Octamer and SPH motifs in the U1 enhancer cooperate to activate U1 RNA gene expression. Mol Cell Biol 10: 341-351, 1990
57. Hernandez N: Small Auclear RNA genes: a model system to study fundamental mechanisms of transcription. J Biol Chem 276(29): 26733-26736, 2001
58. Blau HM: Differentiation requires continuous active control. Ann Rev Biochem 61: 1213-1230, 1992
59. Mimoto J, Kiura K, Matsuo K, Yoshino T, Takata I, Ueoka H, kataoka M, Harada M: (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis 21(5): 915-919, 2000
60. Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H: Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 20(6): 1233-1239, 2002
61. Frei B, Higdon JV: Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133(10): 3275S-3284S, 2003
62. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19(4): 611-616, 1998
63. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H: Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer res 88(7): 639-643, 1997
64. Hofmann CS, Sonenshein GE: Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J 17(6): 702-704, 2003
65. Bode AM, Dong Z: Signal Transduction pathways: targets for green and black tea polyphenols. J. Biochem Mol Biol 36(1): 66-77, 2003
66. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nature reviews (Cancer) 3: 768-780, 2003